Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
12 hedge funds and large institutions have $220K invested in Allied Healthcare Products in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
47% less capital invested
Capital invested by funds: $414K → $220K (-$194K)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$5.51K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.34K |
| 3 |
Citigroup
New York
|
+$129 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$42.1K |
| 2 |
Renaissance Technologies
New York
|
-$29.9K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$29.3K |
| 4 |
Millennium Management
New York
|
-$25K |
| 5 |
HF
HRT Financial
New York
|
-$24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $61K | -$42.1K | -22,951 | -33% |
|
|
2
Renaissance Technologies
New York
| $59K | -$29.9K | -16,300 | -27% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $29K | – | – | – |
|
|
4
Dimensional Fund Advisors
Austin,
Texas
| $27K | -$29.3K | -15,962 | -44% |
|
|
SSA
5
Schonfeld Strategic Advisors
New York
| $24K | -$184 | -100 | -0.6% |
|
|
TDC
6
Thompson Davis & Co
Richmond,
Virginia
| $17K | +$5.51K | +3,000 | +30% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3K | +$4.34K | +2,362 | New |
|
|
8
Millennium Management
New York
| – | -$25K | -15,578 | Closed |
|
|
HF
9
HRT Financial
New York
| – | -$24K | -15,293 | Closed |
|
10
Morgan Stanley
New York
| – | -$14.8K | -8,052 | -100% |
|
|
11
Citigroup
New York
| – | +$129 | +70 | New |
|
AHPI Hedge Fund Activity: Q3 2022 in Review
12 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q3 2022, worth a combined $220K — down 47% from $414K a quarter earlier.
Fund positioning in AHPI was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 5 trimmed.
The largest buyer was Thompson Davis & Co, adding an estimated $5.51K. The largest seller was Vanguard Group, cutting an estimated $42.1K.
- 12 institutional investors held Allied Healthcare Products (AHPI) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $220K of Allied Healthcare Products stock for Q3 2022, down 47% quarter-over-quarter.
- 2 funds opened new Allied Healthcare Products positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest Allied Healthcare Products buyer in Q3 2022 was Thompson Davis & Co, an estimated $5.51K added.
- The largest Allied Healthcare Products seller in Q3 2022 was Vanguard Group, an estimated $42.1K sold.
Based on aggregated 13F filings for Q3 2022.